Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of Petco Health & Wellness Company, Inc. from 01 Feb 2020 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Petco Health & Wellness Company, Inc. annual and quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 01 Feb 2020 to 31 Jan 2026.
  • Petco Health & Wellness Company, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 03 May 2025 was $42,921,000, a 6.3% increase year-over-year.
  • Petco Health & Wellness Company, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2025 was $87,747,000, a 95% increase from 2024.
  • Petco Health & Wellness Company, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $45,016,000.
  • Petco Health & Wellness Company, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $77,078,000, a 844% decline from 2022.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)

Petco Health & Wellness Company, Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $87,747,000 +$42,731,000 +95% 02 Feb 2025 31 Jan 2026 10-K 13 Mar 2026 2025 FY
2024 $45,016,000 +$122,094,000 04 Feb 2024 01 Feb 2025 10-K 13 Mar 2026 2025 FY
2023 $77,078,000 -$68,915,000 -844% 29 Jan 2023 03 Feb 2024 10-K 13 Mar 2026 2025 FY
2022 $8,163,000 -$110,513,000 -108% 30 Jan 2022 28 Jan 2023 10-K 31 Mar 2025 2024 FY
2021 $102,350,000 +$137,528,000 31 Jan 2021 29 Jan 2022 10-K 03 Apr 2024 2023 FY
2020 $35,178,000 -$3,403,000 -11% 02 Feb 2020 30 Jan 2021 10-K 28 Mar 2023 2022 FY
2019 $31,775,000 03 Feb 2019 01 Feb 2020 10-K 24 Mar 2022 2021 FY

Petco Health & Wellness Company, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $42,921,000 +$2,864,000 +6.3% 02 Feb 2025 03 May 2025 10-Q 06 Jun 2025 2025 Q1
Q1 2024 $45,785,000 +$16,421,000 +26% 04 Feb 2024 04 May 2024 10-Q 06 Jun 2025 2025 Q1
Q1 2023 $62,206,000 -$38,555,000 -163% 29 Jan 2023 29 Apr 2023 10-Q 05 Jun 2024 2024 Q1
Q1 2022 $23,651,000 -$84,089,000 -139% 30 Jan 2022 30 Apr 2022 10-Q 07 Jun 2023 2023 Q1
Q1 2021 $60,438,000 -$133,130,000 -69% 31 Jan 2021 01 May 2021 10-Q 09 Jun 2022 2022 Q1
Q1 2020 $193,568,000 02 Feb 2020 02 May 2020 10-Q 10 Jun 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.